Literature DB >> 6314195

Interactions of ethyl-beta-carboline-3-carboxylate and Ro 15-1788 with CGS 8216 in an animal model of anxiety.

S E File, R G Lister.   

Abstract

The effect of CGS 8216 (10 mg/kg) alone and in combination with the imidazodiazepine Ro 15-1788 (10 mg/kg) or ethyl-beta-carboline-3-carboxylate (beta-CCE 1 mg/kg) was tested in the social interaction test of anxiety. All 3 compounds were found to have an anxiogenic action. When Ro 15-1788 or beta-CCE was combined with CGS 8216, no mutual antagonism of the drugs' effects was observed. The failure of Ro 15-1788 to antagonize the anxiogenic action of CGS 8216 raises the possibility that CGS 8216 might be acting at a non-benzodiazepine site.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6314195     DOI: 10.1016/0304-3940(83)90170-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Effects of a single or repeated administration of the benzodiazepine inverse agonist FG7142 on behaviour and cortical adrenoceptor binding in the rat.

Authors:  S C Stanford; H A Baldwin; S E File
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  The benzodiazepine antagonist CGS 8216 decreases both shocked and unshocked drinking in rats.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Benzodiazepine receptor ligands and the consumption of a highly palatable diet in non-deprived male rats.

Authors:  S J Cooper; D J Barber; D B Gilbert; W R Moores
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 4.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Actions of the beta-carboline ZK 93426 in an animal test of anxiety and the holeboard: interactions with Ro 15-1788.

Authors:  S E File; S Pellow; L H Jensen
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

6.  Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat.

Authors:  V Santucci; M Fournier; P Worms; P Keane; K Bizière
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

7.  A pharmacokinetic study of CGS-8216, a benzodiazepine receptor ligand, in the rat.

Authors:  R G Lister; D J Greenblatt; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 8.  Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations.

Authors:  S Pellow; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties.

Authors:  J A Miller; M W Dudley; J H Kehne; S M Sorensen; J M Kane
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

10.  Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation.

Authors:  Yan Clément; Anne-Marie Le Guisquet; Patrice Venault; Georges Chapouthier; Catherine Belzung
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.